MENU
GLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Greenwich LifeSciences (GLSI) Ownership - Who owns Greenwich LifeSciences?

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences... Show more

Profile

Industry
N/A
Address
3992 Bluebonnet Drive
Phone
+1 832 819-3232
Employees
13
Web
https://www.greenwichlifesciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
272.87M
P/E Ratio
N/A
Total Cash
8.88M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash/Share
0.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Greenwich LifeSciences? GLSI symbol Ownership - Tickeron.com